Open AccessRelapses in people with multiple sclerosis treated with cladribine tablets followed for up to 5 years: a plain language summary
Author(s) -
Nicola De Stefano,
Maria Pia Sormani,
Gavin Giovani,
Kottil Rammohan,
Thomas Leist,
Patricia K. Coyle,
Fernando Dangond,
Nektaria Alexandri,
Andrew Galazka
Publication year - 2022
Publication title -
neurodegenerative disease management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.674
H-Index - 23
eISSN - 1758-2032
pISSN - 1758-2024
DOI - 10.2217/nmt-2022-0019
Subject(s) - cladribine , clarity , placebo , medicine , pill , multiple sclerosis , dosing , alternative medicine , pharmacology , psychiatry , pathology , biochemistry , chemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom